Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Transmission of drug-resistant tuberculosis in HIV-endemic settings.
KHAN, PY; Yates, TA; Osman, M; Warren, RM; Van der Heijden, Y; Padayatchi, N; Nardell, EA; MOORE, D; Mathema, B; Gandhi, N; Eldholm, V; DHEDA, K; Hesseling, AC; Mizrahi, V; Rustomjee, R; Pym, A;
2018
LANCET INFECTIOUS DISEASES, (2018).19 3 10.1016/S1473-3099(18)30537-1.
Metabolite changes in blood predict the onset of tuberculosis.
Weiner, J; Maertzdorf, J; SUTHERLAND, JS; Duffy, FJ; Thompson, E; Suliman, S; McEwen, G; Thiel, B; Parida, SK; Zyla, J; Hanekom, WA; Mohney, RP; Boom, WH; Mayanja-Kizza, H; Howe, R; DOCKRELL, HM; Ottenhoff, TH M; Scriba, TJ; Zak, DE; Walzl, G; Kaufmann, SH E; GC6-74 consortium,;
2018
Nature Communications, (2018).9 1 10.1038/s41467-018-07635-7.
Validation of the FluoroType<sup>®</sup> MTBDR assay using respiratory and lymph node samples.
Haasis, C; Rupp, J; Andres, S; Schlüter, B; Kernbach, M; Hillemann, D; KRANZER, K;
2018
Tuberculosis (Edinburgh, Scotland), (2018).113, 10.1016/j.tube.2018.09.004.
Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid.
Requena-Méndez, A; Davies, G; Waterhouse, D; Ardrey, A; Jave, O; López-Romero, SL; Ward, SA; MOORE, DA J;
2018
The Journal of antimicrobial chemotherapy, (2018).74 2 10.1093/jac/dky444.
Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru.
Obregón, G; Zevallos, K; Alarcón, V; Puyén, ZM; Chávez Inagaki, O; Mendoza-Ticona, A; Alarcón-Arrascue, E; Heldal, E; MOORE, DA J;
2018
The international journal of tuberculosis and lung disease, (2018).22 11 10.5588/ijtld.17.0894.
Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.
Villarreal, J; Alarcón, V; Alarcón-Arrascue, E; MOORE, DA J; Heldal, E; Mendoza-Ticona, A;
2018
The international journal of tuberculosis and lung disease, (2018).22 11 10.5588/ijtld.17.0911.
The Importance of Heterogeneity to the Epidemiology of Tuberculosis.
Trauer, JM; Dodd, PJ; Gomes, MG M; Gomez, GB; HOUBEN, RM G J; McBryde, ES; Melsew, YA; Menzies, NA; Arinaminpathy, N; Shrestha, S; Dowdy, DW;
2018
Clinical infectious diseases, (2018).69 1 10.1093/cid/ciy938.
Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia.
Dale, KD; Trauer, JM; Dodd, PJ; HOUBEN, RM G J; Denholm, JT;
2018
The European respiratory journal, (2018).52 6 10.1183/13993003.01218-2018.
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.
Lubbers, R; SUTHERLAND, JS; Goletti, D; De Paus, RA; Van Moorsel, CH M; Veltkamp, M; Vestjens, SM T; Bos, WJ W; Petrone, L; Del Nonno, F; Bajema, IM; Dijkman, K; Verreck, FA W; Walzl, G; Gelderman, KA; Groeneveld, GH; Geluk, A; Ottenhoff, TH M; Joosten, SA; Trouw, LA;
2018
FRONTIERS IN IMMUNOLOGY, (2018).9 OCT 10.3389/fimmu.2018.02427.
"Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.
Kielmann, K; Vidal, N; Riekstina, V; Krutikov, M; Van der Werf, MJ; Biraua, E; Duric, P; MOORE, DA J;
2018
PloS one, (2018).13 10 10.1371/journal.pone.0203937.